NSE ScannerInsurance · Life/Health Insurance · NSE: ICICILIFE · data 2026-10-30
ICICI Life Insurance Ltd
In plain words
Price: 42.0% below its 52-week high of ₹706.8.
Latest results: a net profit of ₹374 cr for the quarter ended Sept 2026 (+26.5% on the same quarter a year earlier).
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹64,595 cr |
| Net profit (last 12 months) | ₹1,608 cr |
| Sales growth, 3 years (yearly) | 7.9% |
| Profit growth, 3 years (yearly) | 25.5% |
At a glance
Promoters 74.7% (+1.8 pts in a year), pledged 0.0%, institutions 20.0%.
P/E 37.1, P/B 4.4, dividend yield 0.4%. Price relative to earnings and book value (low is cheaper, not better).
ROE 12.6%, operating margin 4.4%: how much profit it earns on the money it uses.
Profit growth 25.5% and sales growth 7.9% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
- Profit grew 25.5% a year over 3 years.
- Promoters raised their holding by 1.8 points in a year.
None flagged by these rules.
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Latest results in brief (Q2 FY27)
ICICILIFE Q2 FY27 results (standalone figures, as filed on NSE).
Income was ₹13,803.9 crore, up 41.6% QoQ.
Net profit was ₹374.22 crore, down 3.1% QoQ.
EPS was ₹2.57, down 3.4% QoQ.
ICICILIFE के Q2 FY27 नतीजे (स्टैंडअलोन आंकड़े, NSE पर दाखिल)।
आय: ₹13,803.9 करोड़; पिछली तिमाही की तुलना में 41.6% की बढ़त।
शुद्ध मुनाफ़ा: ₹374.22 करोड़; पिछली तिमाही की तुलना में 3.1% की गिरावट।
EPS: ₹2.57; पिछली तिमाही की तुलना में 3.4% की गिरावट।
ICICILIFEના Q2 FY27 પરિણામો (સ્ટેન્ડઅલોન આંકડા, NSE પર ફાઇલ કરેલા).
આવક: ₹13,803.9 કરોડ; ગયા ક્વાર્ટરની સરખામણીએ 41.6% વધારો.
ચોખ્ખો નફો: ₹374.22 કરોડ; ગયા ક્વાર્ટરની સરખામણીએ 3.1% ઘટાડો.
EPS: ₹2.57; ગયા ક્વાર્ટરની સરખામણીએ 3.4% ઘટાડો.
Written from the filed numbers. Not a recommendation.
Smart-money activity
5/100 · Weak over the last ~60 sessions
- Delivery vs usual 0/30: No stored daily delivery history for this stock (0 points).
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
- 13 Oct 26Results Q2 FY27 results: net profit ₹374.2 cr
- 15 Jul 26Results Q1 FY27 results: net profit ₹386.2 cr
- 13 Jul 26Results Q4 FY26 results: profit +61.9% YoY
- 5 Jun 26Dividend Dividend ₹1.65 (ex-date)
- 14 Jan 26Results Q3 FY26 results: net profit ₹387.1 cr
- 15 Oct 25Results Q2 FY26 results: net profit ₹295.8 cr
- 15 Jul 25Results Q1 FY26 results: net profit ₹301 cr
- 12 Jun 25Dividend Dividend ₹0.85 (ex-date)
- 21 Apr 25Results Q4 FY25 results: net profit ₹385.3 cr
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Quarterly results (consolidated)
| Quarter | Revenue | Net profit | Profit YoY | Op. margin | EPS ₹ |
|---|---|---|---|---|---|
| Sept 2026 | ₹13,804 cr | ₹374 cr | +26.5% | — | 2.57 |
| Jun 2026 | ₹9,749 cr | ₹386 cr | +28.3% | — | 2.66 |
| Mar 2026 | ₹19,180 cr | ₹624 cr | +61.9% | — | 4.28 |
| Dec 2025 | ₹11,809 cr | ₹387 cr | — | — | 2.66 |
Shareholding trend
| Holder | Sept 2026 | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|---|
| Promoters | 74.70% | 72.73% | 72.80% | 72.88% |
| Foreign institutions (FII) | 9.26% | 10.22% | 10.90% | 11.48% |
| Domestic institutions (DII) | 10.76% | 11.82% | 11.05% | 10.41% |
| Mutual funds | 9.30% | 10.39% | 9.45% | 8.37% |
| Retail investors | 2.10% | 2.07% | 2.19% | 2.22% |
| Number of shareholders | 3,22,061 | 3,19,872 | 3,27,841 | 3,36,234 |
Common questions
What was ICICI Life Insurance Ltd's latest quarterly profit?
ICICI Life Insurance Ltd reported a net profit of ₹374 cr for the quarter ended Sept 2026 (+26.5% on the same quarter a year earlier), on revenue of ₹13,804 cr.
How much do promoters hold in ICICI Life Insurance Ltd?
Promoters held 74.70% of ICICI Life Insurance Ltd at the end of Sept 2026, with 0.00% of promoter shares pledged.
Is ICICI Life Insurance Ltd debt-free?
Its latest reported debt-to-equity ratio is 0.19.
What is ICICI Life Insurance Ltd's P/E ratio?
About 37.1, based on the last 12 months' earnings and a price of ₹410 (data 2026-10-30).
What is the 52-week high and low of ICICI Life Insurance Ltd?
The 52-week high is ₹706.8 and the 52-week low is ₹401.65.
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| ICICI Life Insurance Ltd | ₹410 | ₹59,791 cr | 37.1 | 4.4 | 12.6% | 0.6% | 0.19 | -31.8% |
| SBI Life Insurance Co. Ltd. | ₹1,658.6 | ₹1,66,160 cr | 62.7 | 8.1 | 13.7% | 0.6% | 0 | -15.8% |
| HDFC Life Insurance Co. Ltd. | ₹524.9 | ₹1,13,659 cr | 55.4 | 5.9 | 11.3% | 0.6% | 0.17 | -30.8% |
| Max Financial Services Limited | ₹1,200 | ₹41,517 cr | 221.9 | 7.2 | 1.6% | — | 0.44 | -21.0% |
| Star Health & Allied Insurance Co. Ltd. | ₹530.4 | ₹31,215 cr | 29.7 | 3 | 7.6% | 4.6% | 0.06 | +10.3% |
| Niva Bupa Health Insurance Company Limited | ₹72.65 | ₹13,432 cr | 37.6 | 3.5 | 10% | 9.8% | 0.1 | -3.5% |
Compare ICICILIFE with SBILIFE in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open ICICILIFE in NSE Scanner →